$ 3,600.00 – $ 6,600.00
- Description
- Sample Request
- Speak to Analyst
- Additional information
- Table of Content
- MARKET SEGMENT
- MAJOR PLAYERS
Description
KACSK Market Research has come up with the latest market research study on- The Global Human Growth Hormone Market was valued at $2,840.60 million in 2018 and is expected to reach $5,562.90 million by 2026, registering a CAGR of 8.7% from 2019 to 2026.
Human growth hormone is a protein made by the pituitary organ and is emitted into the circulation system to different pieces of the body. Its creation is controlled by a multifaceted arrangement of hormones delivered in the nerve center organ, intestinal tract, and pancreas. Further, these hormones follow up on a few tissues all through the body. In young people, it invigorates the growth of bone and ligament. Though in grown-ups, it helps protein creation, advances the usage of fat, meddles with the activity of insulin, and raises glucose levels. GH likewise raises levels of insulin-like growth factor1.
Surge in mindfulness with respect to the viability of growth hormones and increment in predominance of incessant maladies including growth impediment and pituitary dysfunctions and surge in consistence for growth hormone plans are the central point that drive the growth of the worldwide human growth hormone showcase. Be that as it may, the reactions related with its vivacious utilization, for example, muscle torment, joint torment, and liquid maintenance and significant expense of the treatment hampers the growth of the market. Also, tough government endorsements are relied upon to control the growth and advancement of the market in the coming years. Besides, ascend in extra cash and surge in human services use in creating economies is foreseen to make rewarding growth open doors for the market.
The human growth hormone market can be portioned based on application, course of organization, dissemination channel, and area. By application, it is arranged into growth hormone insufficiency, Prader-Willi disorder, Turner disorder, and little for gestational age, and others. By course of organization, it is ordered into intravenous, intramuscular, subcutaneous, and oral. Based on conveyance channel, it is isolated into emergency clinic drug store, retail drug store, center, and online drug store. District savvy, it is dissected across North America, Asia-Pacific, Europe, and LAMEA.
Historical data 2015 to 2018
Base year for estimation 2019
Forecast period 2020 to 2026
Our Research covers Competitors:
1- Company Profile
2- Main Business Information
3- SWOT Analysis
4- Sales, Revenue, Price and Gross Margin
5- Market Share
Reasons to Buy:
1- Our Research study will provide you to understand the key market trends, challenges, Market Size, Market Key Players, Market Insights, SWOT analysis and opportunities in the industries.
2- Reliable Data Source
3- Distribution Channel sales Analysis by Value
4- Analysing the outlook of the market with the recent trends and SWOT and PESTLE analysis
5- 1-year analyst support, along with the data support in excel format.
6- Study providing the data from the different segments of the industry
7- Free Customization as per your requirement.
8- Market Segmentation analysis provide you the Quantitative and Qualitative data
** In-Depth Analysis, Actual number and Market Size Estimation Available in Full Report.
Thanks for reading this article, you can also avail individual region wise chapter wise section report version like Europe or Asia. North America. Asia Pacific and Global.
Browse other related Report-
https://kacskmarketresearch.com/market-research/utilities-misc/
Human Growth Hormone Market, Human Growth Hormone Market Trends, Human Growth Hormone Market Analysis, Human Growth Hormone Market Size, Human Growth Hormone Market Share, Human Growth Hormone Market Industry, Human Growth Hormone Market Growth, Human Growth Hormone Market News
Request for Sample
Speak to us.
Additional information
| License | Single, Enterprise |
|---|
Table of Content
Human Growth Hormone Market
Table of Content
1. Research Framework
1.1. Research Objective
1.2. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Industry Participants
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation
3. Executive Summary
3.1. Overview
4. Market Dynamics
4.1. Industry Value Chain Analysis
4.1.1. Raw Material Provider
4.1.2. Manufacturer/Producer
4.1.3. Distributor
4.1.4. End User
4.2. Global Industry Outlook
4.3. Porter’s Five Forces Model
4.4. Market Potential
4.5. COVID-19 Impact Assessment on Market
4.5.1. V Shaped Recovery
4.5.2. U Shaped Recovery
4.5.3. L Shaped Recovery
4.5.4. W Shaped Recovery
4.6. COVID-19 Impact Assessment on Market
4.6.1. Drivers
4.6.2. Restraints
4.6.3. Opportunities
4.6.4. Challenges
4.7. Major Strategies Adopted by Key Players
4.8. Market Positioning of Key Players
5. Global Human Growth Hormone Market Analysis, by Application
5.1. Key Insights
5.2. Market Size and Forecast, 2018-2028 (USD Mn)
5.2.1. Growth Hormone Deficiency
5.2.2. Prader-Willi Syndrome
5.2.3. Turner Syndrome
5.2.4. Small for Gestational Age
5.2.5. Others
6. Global Human Growth Hormone Market Analysis, by (Product Type)
6.1. Key Insights
6.2. Market Size and Forecast, 2018-2028 (USD Mn)
6.2.1. Intravenous
6.2.2. Intramuscular
6.2.3. Subcutaneous
6.2.4. Oral
7. Global Human Growth Hormone Market Analysis, by (Distribution Channel)
7.1. Key Insights
7.1.1. Market Size and Forecast, 2018-2028 (USD Mn)
7.1.2. Hospital Pharmacy
7.1.3. Retail Pharmacy
7.1.4. Clinics
7.1.5. Online Pharmacy
8. Global Human Growth Hormone Market, by Geography, 2018-2030 (US$ Bn)
8.1. Key Insights
8.2. Market Size and Forecast, 2018-2028 (USD Mn)
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
9. North America Human Growth Hormone Market Analysis
9.1. Key Insights
9.2. Market Size and Forecast, 2018-2028 (USD Mn)
9.2.1. By Application
9.2.2. Growth Hormone Deficiency
9.2.3. Prader-Willi Syndrome
9.2.4. Turner Syndrome
9.2.5. Small for Gestational Age
9.2.6. Others
9.2.7. By Product Type
9.2.8. Intravenous
9.2.9. Intramuscular
9.2.10. Subcutaneous
9.2.11. Oral
9.2.12. By Distribution Channel
9.2.13. Hospital Pharmacy
9.2.14. Retail Pharmacy
9.2.15. Clinics
9.2.16. Online Pharmacy
9.2.17. By Country
9.2.17.1. United States (U.S.)
9.2.17.2. Canada
10. Europe Human Growth Hormone Market Analysis
10.1. Key Insights
10.2. Market Size and Forecast, 2018-2028 (USD Mn)
10.2.1. By Application
10.2.2. Growth Hormone Deficiency
10.2.3. Prader-Willi Syndrome
10.2.4. Turner Syndrome
10.2.5. Small for Gestational Age
10.2.6. Others
10.2.7. By Product Type
10.2.8. Intravenous
10.2.9. Intramuscular
10.2.10. Subcutaneous
10.2.11. Oral
10.2.12. By Distribution Channel
10.2.13. Hospital Pharmacy
10.2.14. Retail Pharmacy
10.2.15. Clinics
10.2.16. Online Pharmacy
10.2.17. By Country
10.2.17.1. United Kingdom (U.K.)
10.2.17.2. Germany
10.2.17.3. France
10.2.17.4. Italy
10.2.17.5. Spain
10.2.17.6. Rest of Europe
11. Asia Pacific Human Growth Hormone Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2018-2028 (USD Mn)
11.2.1. By Application
11.2.2. Growth Hormone Deficiency
11.2.3. Prader-Willi Syndrome
11.2.4. Turner Syndrome
11.2.5. Small for Gestational Age
11.2.6. Others
11.2.7. By Product Type
11.2.8. Intravenous
11.2.9. Intramuscular
11.2.10. Subcutaneous
11.2.11. Oral
11.2.12. By Distribution Channel
11.2.13. Hospital Pharmacy
11.2.14. Retail Pharmacy
11.2.15. Clinics
11.2.16. Online Pharmacy
11.2.17. By Country
11.2.17.1. Japan
11.2.17.2. China
11.2.17.3. India
11.2.17.4. Rest of Asia Pacific
12. Latin America Human Growth Hormone Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2018-2028 (USD Mn)
12.2.1. By Application
12.2.2. Growth Hormone Deficiency
12.2.3. Prader-Willi Syndrome
12.2.4. Turner Syndrome
12.2.5. Small for Gestational Age
12.2.6. Others
12.2.7. By Product Type
12.2.8. Intravenous
12.2.9. Intramuscular
12.2.10. Subcutaneous
12.2.11. Oral
12.2.12. By Distribution Channel
12.2.13. Hospital Pharmacy
12.2.14. Retail Pharmacy
12.2.15. Clinics
12.2.16. Online Pharmacy
By Country
12.2.16.1. Brazil
12.2.16.2. Mexico
12.2.16.3. Rest of Latin America
13. Middle East & Africa Human Growth Hormone Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2018-2028 (USD Mn)
13.2.1. By Application
13.2.2. Growth Hormone Deficiency
13.2.3. Prader-Willi Syndrome
13.2.4. Turner Syndrome
13.2.5. Small for Gestational Age
13.2.6. Others
13.2.7. By Product Type
13.2.8. Intravenous
13.2.9. Intramuscular
13.2.10. Subcutaneous
13.2.11. Oral
13.2.12. By Distribution Channel
13.2.13. Hospital Pharmacy
13.2.14. Retail Pharmacy
13.2.15. Clinics
13.2.16. Online Pharmacy
13.2.17. By Country
13.2.17.1. GCC Countries
13.2.17.2. Rest of Middle East & Africa
14. Company Profiles
14.1. Company 1- Novo Nordisk
14.1.1. Company Basic Information, Manufacturing Base, Sales Area
14.1.2. Company Sales and Net Income Highlights
14.1.3. Business Overview
14.1.4. Company News
14.2. Company 2- Merck & Co., Inc
14.2.1. Company Basic Information, Manufacturing Base, Sales Area
14.2.2. Company Sales and Net Income Highlights
14.2.3. Business Overview
14.2.4. Company News
14.3. Company 3- Eli Lilly and Company
14.3.1. Company Basic Information, Manufacturing Base, Sales Area
14.3.2. Company Sales and Net Income Highlights
14.3.3. Business Overview
14.3.4. Company News
14.4. Company 4- Pfizer Inc.
14.4.1. Company Basic Information, Manufacturing Base, Sales Area
14.4.2. Company Sales and Net Income Highlights
14.4.3. Business Overview
14.4.4. Company News
14.5. Company 5- Teva Pharmaceutical Industries Ltd
14.5.1. Company Basic Information, Manufacturing Base, Sales Area
14.5.2. Company Sales and Net Income Highlights
14.5.3. Business Overview
14.5.4. Company News
14.6. Company 6- Novartis AG
14.6.1. Company Basic Information, Manufacturing Base, Sales Area
14.6.2. Company Sales and Net Income Highlights
14.6.3. Business Overview
14.6.4. Company News
14.7. Company 7- AnkeBio Co. Ltd
14.7.1. Company Basic Information, Manufacturing Base, Sales Area
14.7.2. Company Sales and Net Income Highlights
14.7.3. Business Overview
14.7.4. Company News
14.8. Company 8- F. Hoffmann-La Roche
14.8.1. Company Basic Information, Manufacturing Base, Sales Area
14.8.2. Company Sales and Net Income Highlights
14.8.3. Business Overview
14.8.4. Company News
14.9. Company 9- Ipsen
14.9.1. Company Basic Information, Manufacturing Base, Sales Area
14.9.2. Company Sales and Net Income Highlights
14.9.3. Business Overview
14.9.4. Company News
14.10. Company 10- Ferring B.V.
14.10.1. Company Basic Information, Manufacturing Base, Sales Area
14.10.2. Company Sales and Net Income Highlights
14.10.3. Business Overview
14.10.4. Company News
14.11. Company – Others Market Players will be Included in the Final Report
14.11.1. Company Basic Information, Manufacturing Base, Sales Area
14.11.2. Company Sales and Net Income Highlights
14.11.3. Business Overview
14.11.4. Company News
Research Findings & Conclusion
MARKET SEGMENT
KEY MARKET SEGMENTS
By Application
Growth Hormone Deficiency
Prader-Willi Syndrome
Turner Syndrome
Small for Gestational Age
Others
By Route of Administration
Intravenous
Intramuscular
Subcutaneous
Oral
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Clinics
Online Pharmacy
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
MAJOR PLAYERS
LIST OF KEY PLAYERS
Novo Nordisk
Merck & Co., Inc
Eli Lilly and Company
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
Novartis AG
AnkeBio Co. Ltd
F. Hoffmann-La Roche
Ipsen
Ferring B.V.